Prepare for your visit

Victoria Dantchenko

Family Medicine · Brooklyn, NY · NPI 1811220924

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$2,695.44

in general payments reported to CMS, 2019-2025 · $487 in 2025

The $487 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

Who reported paying

General payments only, top 6 by amount.

Abbvie INC. $516.33
Astrazeneca Pharmaceuticals LP $502.47
Glaxosmithkline, LLC. $170.67
Bayer Healthcare Pharmaceuticals INC. $168.66
Daiichi Sankyo INC. $124.03
Novo Nordisk INC $99.87

Drugs and devices associated with these payments

Shingrix Arexvy Qulipta Kerendia Airsupra Ubrelvy Veozah Eliquis Heplisav-B The Cologuard Plus Collection Kit Nurtec Odt Cequr Simplicity

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Victoria Dantchenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/218588/victoria-dantchenko